Cargando...
Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a highly malignant human cancer that has increasing mortality rates worldwide. Because CD133(+) cells control tumor maintenance and progression, compounds that target CD133(+) cancer cells could be effective in combating HCC. We found that the administration of chro...
Guardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7281429/ https://ncbi.nlm.nih.gov/pubmed/32397206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051193 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|